Literature DB >> 24672176

Prevalence and distribution of schistosomiasis in afder and gode zone of somali region, ethiopia.

Nebiyu Negussu1, Mohamed Wali2, Milion Ejigu3, Fikiru Debebe4, Sirage Aden5, Rashid Abdi6, Yusuf Mohamed6, Amare Deribew7, Kebede Deribe8.   

Abstract

BACKGROUND: There is no recent information about the prevalence and distribution of schistosomiasis in the Somali national regional state of Ethiopia. Ethiopia launched the national integrated neglected tropical diseases (NTDs) Master Plan in June 2013. The Master Plan identified mapping NTDs as a prerequisite for launching control programs. Therefore it is important to understand the prevalence and distribution of schistosomiasis in respective regions.
MATERIALS AND METHODS: From February to March 2011, a cross-sectional survey was done in school-aged children from six districts of Afder Gode zone. Urine samples were collected and examined for ova of Schistosoma haematobium using the sedimentation technique and stool samples were collected and examined for S. mansoni using the Kato-Katz technique. A semistructured questionnaire was used to collect sociodemographic characteristics of the participants.
RESULTS: Of the 523 children, 513 (98%) of them participated in the study. The prevalence of S. haematobium was 16.0% (95% confidence interval (CI); 12.8-19.2). The rate of the disease was not uniform across the various six communities studied (x(2) = 208.8, P < 0.0001). Musthail district had the highest prevalence with 64.2% (95% CI; 60.0-68.3) followed by Kelafo with 11.8% (95% CI; 9.0-14.6). No infections of S. mansoni were found in these settings. There was no difference in the prevalence of infection across age groups. Boys were more likely to be infected by S. haematobium than girls (odds ratio = 1.68; 95% CI: 1.1-2.7).
CONCLUSION: S. haematobium infection is prevalent in the region with varying distribution across the districts. According to the World Health Organization, mass drug administration should be considered in some of the districts.

Entities:  

Keywords:  S. haematobium; S. mansoni; Schistosomiasis

Year:  2013        PMID: 24672176      PMCID: PMC3958984          DOI: 10.4103/0974-777X.122007

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


  6 in total

1.  Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control.

Authors:  Narcis B Kabatereine; Simon Brooker; Edridah M Tukahebwa; Francis Kazibwe; Ambrose W Onapa
Journal:  Trop Med Int Health       Date:  2004-03       Impact factor: 2.622

Review 2.  Schistosomiasis and pregnancy.

Authors:  Jennifer F Friedman; Priya Mital; Hemal K Kanzaria; G Richard Olds; Jonathan D Kurtis
Journal:  Trends Parasitol       Date:  2007-03-01

3.  Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya.

Authors:  C H King; C E Keating; J F Muruka; J H Ouma; H Houser; T K Siongok; A A Mahmoud
Journal:  Am J Trop Med Hyg       Date:  1988-10       Impact factor: 2.345

Review 4.  Schistosomiasis research and the European Community.

Authors:  P Hagan; B Gryseels
Journal:  Trop Geogr Med       Date:  1994

5.  High prevalence of urinary schistosomiasis in two communities in South Darfur: implication for interventions.

Authors:  Kebede Deribe; Abdeljbar Eldaw; Samir Hadziabduli; Emmanuel Kailie; Mohamed D Omer; Alam E Mohammed; Tanole Jamshed; Elmonshawe A Mohammed; Ali Mergani; Gafar A Ali; Khalid Babikir; Abdulrahman Adem; Farouq Hashim
Journal:  Parasit Vectors       Date:  2011-02-07       Impact factor: 3.876

6.  Prevalence distribution and risk factors for Schistosoma hematobium infection among school children in Blantyre, Malawi.

Authors:  Atupele P Kapito-Tembo; Victor Mwapasa; Steven R Meshnick; Young Samanyika; Dan Banda; Cameron Bowie; Sarah Radke
Journal:  PLoS Negl Trop Dis       Date:  2009-01-20
  6 in total
  6 in total

1.  Prevalence of urinary schistosomiasis and associated risk factors among Abobo Primary School children in Gambella Regional State, southwestern Ethiopia: a cross sectional study.

Authors:  Shashie Geleta; Agersew Alemu; Sisay Getie; Zeleke Mekonnen; Berhanu Erko
Journal:  Parasit Vectors       Date:  2015-04-10       Impact factor: 3.876

2.  Prevalence and Risk Factors for Schistosomiasis among Schoolchildren in two Settings of Côte d'Ivoire.

Authors:  Etienne K Angora; Jérôme Boissier; Hervé Menan; Olivier Rey; Karim Tuo; Andre O Touré; Jean T Coulibaly; Aboulaye Méité; Giovanna Raso; Eliézer K N'Goran; Jürg Utzinger; Oliver Balmer
Journal:  Trop Med Infect Dis       Date:  2019-07-23

3.  Prevalence of Schistosomiasis (S. mansoni and S. haematobium) and its association with gender of school age children in Ethiopia: A systematic review and meta-analysis.

Authors:  Demelash Woldeyohannes; Biniaym Sahiledengle; Yohannes Tekalegn; Zeleke Hailemariam
Journal:  Parasite Epidemiol Control       Date:  2021-03-13

4.  Comparing the accuracy of two diagnostic methods for detection of light Schistosoma haematobium infection in an elimination setting in Wolaita Zone, South Western Ethiopia.

Authors:  Hussein Mohammed; Toby Landeryou; Melkie Chernet; Ewnetu Firdawek Liyew; Yonas Wulataw; Birhanu Getachew; Hailemariam Difabachew; Anna Phillips; Rosie Maddren; Alison Ower; Kalkidan Mekete; Habtamu Belay; Tujuba Endrias; Ufaysa Anjulo; Geremew Tasew; Roy Anderson; Getachew Tollera; Ebba Abate
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

Review 5.  An Epidemiological Trend of Urogenital Schistosomiasis in Ethiopia.

Authors:  Bayissa Chala; Workineh Torben
Journal:  Front Public Health       Date:  2018-03-05

6.  National mapping of soil-transmitted helminth and schistosome infections in Ethiopia.

Authors:  Gemechu Tadesse Leta; Kalkidan Mekete; Yonas Wuletaw; Abeba Gebretsadik; Heven Sime; Sindew Mekasha; Adugna Woyessa; Oumer Shafi; Jozef Vercruysse; Jack E T Grimes; Iain Gardiner; Michael French; Bruno Levecke; Lesley Drake; Wendy Harrison; Alan Fenwick
Journal:  Parasit Vectors       Date:  2020-09-01       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.